# ABioGram > ABioGram develops digital solutions that turn infection data into clinical and healthcare management decisions. The company specializes across the infection diagnosis and treatment continuum – from obtaining and interpreting microbiology results to applying local data in antimicrobial therapy decisions. Domain expertise in clinical microbiology and clinical pharmacology is combined with medical software development and integration into healthcare IT environments. Areas of development include microbiology and molecular-genomic data, AMR surveillance, analytics, and decision support. Molecular-genomic tools are under development; these areas are not four separate ready-to-deploy products. The company's principal deployable product is the ABioGram reference-information system for antimicrobial susceptibility result validation, microbiology reporting, LIS/HIS exchange, and real-time AMR surveillance based on validated data. ## Purpose and attribution of materials The website contains company product information, explanatory reviews of scientific publications, implementation cases, analytical reports, and documents. Review pages are not the original scientific articles. Original authors, journal, DOI, citation, and an available source PDF are identified on each material page. Publication of a review does not imply affiliation of the journal or all authors of the original work with ABioGram. ## Key pages - [Home](https://abiogram.ru/en/): company positioning, areas of development, flagship product, deployment scale, case studies, and publications. - [ABioGram system](https://abiogram.ru/en/abiogram/): LIS/HIS integration, validation of susceptibility results for organisms isolated from patients, local etiology and AMR analysis, and estimation of agent and regimen activity for antimicrobial therapy support. - [Resources and practice](https://abiogram.ru/en/blog/): publications, implementation cases, analytical reports, and documents. - [Company](https://abiogram.ru/en/company/): company information. - [Software specifications](https://abiogram.ru/en/about/): official software information and documents. - [Contact](https://abiogram.ru/en/contact/): official contact information. ## New publications: genomics, phenotype, and machine learning - [From genotype to phenotype: the EUCAST position on WGS](https://abiogram.ru/en/blog/wgs-antimicrobial-susceptibility-eucast-2025/): review of the 2025/2026 EUCAST update on the potential and limitations of predicting bacterial antimicrobial susceptibility from whole-genome sequencing; DOI `10.1016/j.cmi.2026.05.012`. - [Can machine learning predict antimicrobial resistance?](https://abiogram.ru/en/blog/machine-learning-antimicrobial-resistance/): review of methods ranging from logistic regression and random forests to graph neural networks and genomic language models; DOI `10.36488/cmac.2026.1.81-91`. - [Whole-genome sequencing](https://abiogram.ru/en/tags/whole-genome-sequencing/): materials on WGS and antimicrobial susceptibility prediction. - [Genotype and phenotype](https://abiogram.ru/en/tags/genotype-phenotype/): materials on linked analysis of genetic markers and phenotypic results. - [Machine learning](https://abiogram.ru/en/tags/machine-learning/): publications on AMR prediction models. - [Artificial intelligence](https://abiogram.ru/en/tags/artificial-intelligence/): materials on AI in microbiology and AMR analysis. ## Other scientific publications and analytics - [From a Microbiology Result to Antimicrobial Stewardship](https://abiogram.ru/en/blog/from-microbiology-result-to-antimicrobial-stewardship/): review of the 2026 SHEA/IDSA/PIDS/SIDP guidance linking microbiology results, treatment decisions, AMR surveillance and outcome evaluation. The system-development matrix is ABioGram's interpretation; [source publication](https://doi.org/10.1017/ash.2026.10344), [PDF](https://abiogram.ru/files/blog/publication/antimicrobial-stewardship-leaders-guidance-2026.pdf). - [Comparison of local AMR surveillance methodologies](https://abiogram.ru/en/blog/2025-publ-surv-cmac/): review of a 2025 CMAC publication with bibliography and DOI. - [Economic loss model for microbiology diagnostic errors](https://abiogram.ru/en/blog/2025-publ-economic-cmac/): review of a 2025 CMAC publication, PDF, and supplementary materials. - [Antimicrobial resistance in Russia, 2025 report](https://abiogram.ru/en/blog/amr-analytic-report-russia-2025/): key findings from the MVC analytical report. - [AMR surveillance materials](https://abiogram.ru/en/tags/amr-surveillance/): thematic index of publications, cases, and reports. - [Antimicrobial resistance materials](https://abiogram.ru/en/tags/amr/): thematic index of AMR materials. - [Antimicrobial susceptibility testing materials](https://abiogram.ru/en/tags/ast/): documents and publications on AST result interpretation. - [Antimicrobial stewardship materials](https://abiogram.ru/en/tags/stewardship/): publications and cases on using data to make and evaluate decisions. ## Documents and terminology resources - [SEMD 256 in microbiology](https://abiogram.ru/en/blog/semd-microbiology/): structure of an electronic microbiology report, antibiogram, MIC, S/I/R, and resistance markers; [CDA implementation archive, edition 1](https://abiogram.ru/files/blog/official-docs/semd-256-microbiology-cda-edition-1.zip), [official EGISZ source page](https://portal.egisz.rosminzdrav.ru/materials/4723). - [NSI dictionaries for antibiogram generation and exchange](https://abiogram.ru/en/blog/nsi-antibiogram-reference-dictionaries/): OIDs and official links for microorganism, antimicrobial agent, standard, interpretation, and resistance-marker dictionaries. - [Russian antimicrobial susceptibility testing guidelines 2026](https://abiogram.ru/en/blog/2026-ast-russia/): official document and PDF. - [EUCAST Breakpoint Tables v16.1](https://abiogram.ru/en/blog/2026.1-ast-eucast/): current update, valid from 24 June 2026, for interpreting MICs and inhibition-zone diameters; [PDF](https://abiogram.ru/files/blog/guide/eucast-breakpoint-tables-v16-1-2026.pdf), [XLSX](https://abiogram.ru/files/blog/guide/eucast-breakpoint-tables-v16-1-2026.xlsx), [dosage tables PDF](https://abiogram.ru/files/blog/guide/eucast-dosage-tables-v16-1-2026.pdf). - [EUCAST Breakpoint Tables v16.0](https://abiogram.ru/en/blog/2026-ast-eucast/): previous version, valid from 1 January 2026. - [Official documents](https://abiogram.ru/en/blog/2026-docs/): healthcare and AMR policy documents. - [Russian Ministry of Health NSI](https://abiogram.ru/en/tags/nsi/): materials on terminology and reference information. - [Health data interoperability](https://abiogram.ru/en/tags/interoperability/): materials on structured health data exchange. - [Structured electronic medical documents](https://abiogram.ru/en/tags/semd/): materials on structured microbiology documents. - [Russian Unified State Health Information System](https://abiogram.ru/en/tags/egisz/): documents and exchange resources related to EGISZ. - [HL7 CDA](https://abiogram.ru/en/tags/hl7-cda/): materials on CDA clinical-document structure. ## Implementation cases - [Regional system in the Yamalo-Nenets Autonomous Okrug](https://abiogram.ru/en/blog/2025-abg-case-ynao/): automated validation of microbiology reports and regional AMR surveillance. - [Closed digital loop at NMRC LRC](https://abiogram.ru/en/blog/2025-abg-case-cmac/): LIS, ABioGram, and HIS integration and analytics based on validated data. - [Pilot in Moscow's largest laboratory](https://abiogram.ru/en/blog/2025-abg-case-mnpcli/): microbiology report validation and API integration results. - [Centralized laboratory at Botkin Hospital](https://abiogram.ru/en/blog/2025-abg-case-botkin-spb/): transition from data exports to continuous surveillance. ## Language - [Русская версия](https://abiogram.ru/llms.txt): Russian website map.